CLINICAL_TRIALS
trial_result
· 2021-08-03
Clinical Trial Update: Adjuvant Melatonin for Prevention of Lung Cancer Recurrence and Mortality [Phase 3]
Summary
Phase 3 trial evaluating adjuvant melatonin for prevention of lung cancer recurrence and mortality has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: The Canadian College of Naturopathic Medicine | Conditions: Non Small Cell Lung Cancer | Phase 3 | Status: COMPLETED | Results posted: 2021-08-03